151 related articles for article (PubMed ID: 26181588)
1. Efficacy Profile of Intracameral Amphotericin B. The Often Forgotten Step.
Sharma B; Kataria P; Anand R; Gupta R; Kumar K; Kumar S; Gupta R
Asia Pac J Ophthalmol (Phila); 2015; 4(6):360-6. PubMed ID: 26181588
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Intracameral Amphotericin B in the Management of Fungal Keratitis: Randomized Controlled Trial.
Sharma N; Sankaran P; Agarwal T; Arora T; Chawla B; Titiyal JS; Tandon R; Satapathy G; Vajpayee RB
Ocul Immunol Inflamm; 2016 Oct; 24(5):493-7. PubMed ID: 26400628
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of intracameral amphotericin B injection in the treatment of fungal keratitis.
Yoon KC; Jeong IY; Im SK; Chae HJ; Yang SY
Cornea; 2007 Aug; 26(7):814-8. PubMed ID: 17667615
[TBL] [Abstract][Full Text] [Related]
4. Cross-Linking-Assisted Infection Reduction: A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Outcomes in Fungal Keratitis.
Prajna NV; Radhakrishnan N; Lalitha P; Austin A; Ray KJ; Keenan JD; Porco TC; Lietman TM; Rose-Nussbaumer J
Ophthalmology; 2020 Feb; 127(2):159-166. PubMed ID: 31619359
[TBL] [Abstract][Full Text] [Related]
5. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
Arora R; Gupta D; Goyal J; Kaur R
Clin Exp Ophthalmol; 2011 Jul; 39(5):434-40. PubMed ID: 21105974
[TBL] [Abstract][Full Text] [Related]
6. Topical amphotericin B and subconjunctival injection of fluconazole (combination therapy) versus topical amphotericin B (monotherapy) in treatment of keratomycosis.
Mahdy RA; Nada WM; Wageh MM
J Ocul Pharmacol Ther; 2010 Jun; 26(3):281-5. PubMed ID: 20565316
[TBL] [Abstract][Full Text] [Related]
7. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Prajna L; Srinivasan M; Raghavan A; Oldenburg CE; Ray KJ; Zegans ME; McLeod SD; Porco TC; Acharya NR; Lietman TM;
JAMA Ophthalmol; 2013 Apr; 131(4):422-9. PubMed ID: 23710492
[TBL] [Abstract][Full Text] [Related]
8. Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial.
Rose-Nussbaumer J; Prajna NV; Krishnan KT; Mascarenhas J; Rajaraman R; Srinivasan M; Raghavan A; Oldenburg CE; O'Brien KS; Ray KJ; McLeod SD; Porco TC; Lietman TM; Acharya NR; Keenan JD;
JAMA Ophthalmol; 2015 Jun; 133(6):642-6. PubMed ID: 25764482
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of intracameral amphotericin B injection in the management of refractory keratomycosis and endophthalmitis.
Yilmaz S; Ture M; Maden A
Cornea; 2007 May; 26(4):398-402. PubMed ID: 17457185
[TBL] [Abstract][Full Text] [Related]
10. Antifungal chemotherapy for fungal keratitis guided by in vivo confocal microscopy.
Shi W; Li S; Liu M; Jin H; Xie L
Graefes Arch Clin Exp Ophthalmol; 2008 Apr; 246(4):581-6. PubMed ID: 18071734
[TBL] [Abstract][Full Text] [Related]
11. Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
Prajna NV; Mascarenhas J; Krishnan T; Reddy PR; Prajna L; Srinivasan M; Vaitilingam CM; Hong KC; Lee SM; McLeod SD; Zegans ME; Porco TC; Lietman TM; Acharya NR
Arch Ophthalmol; 2010 Jun; 128(6):672-8. PubMed ID: 20547942
[TBL] [Abstract][Full Text] [Related]
12. Assessment safety and efficacy of a combination therapy of topical amphotericin B and subconjunctival fluconazole for the treatment of fungal keratitis.
Mahdy RA; Nada WM; Wageh MM; Kader MA; Saleh MM; Alswad MM
Cutan Ocul Toxicol; 2010 Sep; 29(3):193-7. PubMed ID: 20462395
[TBL] [Abstract][Full Text] [Related]
13. Intracameral amphotericin B: initial experience in severe keratomycosis.
Kaushik S; Ram J; Brar GS; Jain AK; Chakraborti A; Gupta A
Cornea; 2001 Oct; 20(7):715-9. PubMed ID: 11588423
[TBL] [Abstract][Full Text] [Related]
14. Intracameral amphotericin B injection in the management of deep keratomycosis.
Kuriakose T; Kothari M; Paul P; Jacob P; Thomas R
Cornea; 2002 Oct; 21(7):653-6. PubMed ID: 12352080
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India.
Vanathi M; Naik R; Sidhu N; Ahmed NH; Gupta N; Tandon R
Indian J Ophthalmol; 2022 Dec; 70(12):4270-4283. PubMed ID: 36453329
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Value of Persistent Culture Positivity in Fungal Keratitis in the Mycotic Antimicrobial Localized Injection Trial.
Pickel J; Narayana S; Krishnan T; Ramakrishnan S; Samantaray PP; Porco TC; Redd T; Lietman TM; Rose-Nussbaumer J
Am J Ophthalmol; 2020 Jul; 215():1-7. PubMed ID: 32171765
[TBL] [Abstract][Full Text] [Related]
17. Mycotic keratitis caused by Scedosporium apiospermum in an immunocompetent patient.
Galvis V; Berrospi R; Tello A; RamÃrez D; Villarreal D
Arch Soc Esp Oftalmol (Engl Ed); 2018 Dec; 93(12):613-616. PubMed ID: 30017419
[TBL] [Abstract][Full Text] [Related]
18. Medical management of Beauveria bassiana keratitis.
Kisla TA; Cu-Unjieng A; Sigler L; Sugar J
Cornea; 2000 May; 19(3):405-6. PubMed ID: 10832710
[TBL] [Abstract][Full Text] [Related]
19. Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.
Sun CQ; Lalitha P; Prajna NV; Karpagam R; Geetha M; O'Brien KS; Oldenburg CE; Ray KJ; McLeod SD; Acharya NR; Lietman TM;
Ophthalmology; 2014 Aug; 121(8):1495-500.e1. PubMed ID: 24746358
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.
Prajna NV; Krishnan T; Rajaraman R; Patel S; Shah R; Srinivasan M; Devi L; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
JAMA Ophthalmol; 2017 Jun; 135(6):520-525. PubMed ID: 28426856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
